Clinical Trial Update: Addition of Vismodegib to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adding vismodegib to neoadjuvant chemotherapy in triple-negative breast cancer patients; the trial status is unknown and no results a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Vismodegib (Vismodegib)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN